Latest News

Here you can find all the latest news from the MRC CTU at UCL.

Our researchers and collaborators will present the latest results of our TB clinical trials, including new findings from the SURE trial.
Results from the RAMPART trial show that giving durvalumab and tremelimumab after surgery helps prevent kidney cancer coming back.
New results from the ICON8B trial were presented at the ESMO 2025 Conference.
Using our multi-arm, multi-stage design, the EJS ACT-PD clinical trial aims to slow or stop the progression of Parkinsons’ disease.
We will present our latest cancer research from the RAMPART, ICON8B and STAMPEDE trials and STOPCAP meta-analysis at the 2025 ESMO Congress.